Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B14 | Q9BPX1 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.30 |
| ▸ | MGAM | O43451 | 1/20 | 0.30 |
| ▸ | NCK1 | P16333 | 1/20 | 0.30 |
| ▸ | BACE1 | P56817 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | CASP6 | P55212 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL263666 | 0.77 | BACE1 (0.50) | HSD17B14CYP1A2BACE1KDM4E | |
| SCHEMBL18463877 | 0.77 | BACE1 (0.50) | HSD17B14CYP1A2BACE1KDM4E | |
| SCHEMBL1644188 | 0.75 | CYP2A6 (0.46) | HSD17B14KDM4E | |
| SCHEMBL14046213 | 0.75 | NPC1 (0.38) | HSD17B14LMNAKDM4E | |
| SCHEMBL21290591 | 0.73 | TDP1 (0.47) | HSD17B14LMNAMGAMKDM4EPOLB | |
| SCHEMBL23268389 | 0.72 | ALDH1A1 (0.39) | LMNAKDM4E | |
| SCHEMBL611196 | 0.72 | MGAM (0.57) | HSD17B14CYP1A2LMNAMGAMKDM4E | |
| SCHEMBL31080661 | 0.72 | MGAM (0.57) | HSD17B14CYP1A2LMNAMGAMKDM4E | |
| SCHEMBL12517671 | 0.72 | CYP1A2 (0.61) | CYP1A2LMNANCK1BACE1KDM4E | |
| SCHEMBL15813419 | 0.71 | NMT1 (0.38) | CYP1A2LMNANCK1BACE1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210115077-A1 | Organometallic compound, organic light-emitting device including the same, and diagnosing composition including the organometallic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210115077-A1 | Organometallic compound, organic light-emitting device including the same, and diagnosing composition including the organometallic compound | L1CAM, MSL1, NOM1 | HSD17B14 2714/4885CYP1A2 150/4885LMNA 1101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.